Table 2 Measures to reduce GBCA and opportunities for implementation
Measures | Opportunities |
|---|---|
To reduce the use of GBCA | Preauthorisation of MRI requests Individualising the volume of GBCA Reducing the amount of contrast media a. Higher-relaxivity GBCA b. Increased enhancement through optimised acquisition c. Increased enhancement through postprocessing d. Alternative sequences requiring no GBCA for clinical task e. Alternative contrast agents |
To reduce the waste of GBCA | Multi-patient injection system |
To collect residues of GBCA | Collection of residues of contrast media Gadolinium recycling services |
To reduce the amount of GBCA excreted into sewage water | Use of urine bags in outpatients Prolonged in-hospital time for outpatients |